-
公开(公告)号:US20120196884A1
公开(公告)日:2012-08-02
申请号:US13378503
申请日:2010-06-14
申请人: Jarkko Tapani Koivunen , Jani Korhonen , Anne Marjamäki , Liisa Nissinen , Marjo Pihlavisto , Olli Taneli Pentikäinen
发明人: Jarkko Tapani Koivunen , Jani Korhonen , Anne Marjamäki , Liisa Nissinen , Marjo Pihlavisto , Olli Taneli Pentikäinen
IPC分类号: A61K31/18 , C07D209/42 , A61K31/404 , C07D231/18 , A61K31/415 , C07D409/04 , A61K31/4155 , C07D413/04 , A61K31/422 , A61K31/4436 , C07D401/04 , A61K31/4439 , C07D417/04 , A61K31/427 , A61K31/4245 , C07D333/34 , A61K31/381 , C07D233/84 , A61K31/4164 , C07D409/14 , C07D277/36 , C07D319/18 , A61K31/357 , C07D213/71 , A61K31/4418 , C07D213/54 , A61K31/506 , C07D231/12 , A61K31/4535 , A61P7/02 , A61P29/00 , A61P35/00 , A61P9/00 , A61P1/00 , A61P17/06 , A61P19/02 , A61P25/00 , A61P11/06 , A61P37/08 , C07C303/40 , C07C303/38 , C07C311/44 , C07C311/29 , A61K31/277 , C07C311/21
CPC分类号: C07D213/75 , C07C311/21 , C07C311/29 , C07C311/47 , C07D209/08 , C07D213/34 , C07D213/40 , C07D213/71 , C07D213/76 , C07D231/12 , C07D231/18 , C07D231/38 , C07D231/40 , C07D233/84 , C07D277/36 , C07D319/18 , C07D333/34 , C07D401/04 , C07D409/04 , C07D409/14 , C07D413/04 , C07D417/04
摘要: The present invention relates to sulphonamide derivatives, whith a urea moiety. The invention also relates to the use of the derivatives as inhibitors of collagen receptor integrins, especially α2β1 integrin inhibitors e.g. in connection with diseases and medical conditions that involve the action of cells and platelets expressing collagen receptors, their use as a medicament, e.g. for the treatment of thrombosis, inflammation, cancer and vascular diseases, pharmaceutical compositions containing them and a process for preparing them. The sulphonamide derivatives have the general formula (I) or (I′).
摘要翻译: 本发明涉及一种尿素部分的磺酰胺衍生物。 本发明还涉及衍生物作为胶原受体整合素抑制剂的用途,特别是α2和bgr1整联蛋白抑制剂。 涉及涉及表达胶原受体的细胞和血小板的作用的疾病和医学病症,它们作为药物的用途,例如, 用于治疗血栓形成,炎症,癌症和血管疾病,含有它们的药物组合物及其制备方法。 磺酰胺衍生物具有通式(I)或(I')。